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Abstract
Background  and  objectives: This  study  compared  the  rates  of  acute  respiratory  failure,  rein-
tubation,  length  of  intensive  care  stay  and  mortality  in  patients  in  whom  the  non-invasive
mechanical  ventilation  (NIMV)  was  applied  instead  of  the  routine  venturi  face  mask  (VM)  appli-
cation after  a  successful  weaning.
Methods:  Following  the  approval  of  the  hospital  ethics  committee,  62  patients  who  were  under
mechanical  ventilation  for  at  least  48  hours  were  scheduled  for  this  study.  12  patients  were
excluded because  of  the  weaning  failure  during  T-tube  trial.  The  patients  who  had  optimum
weaning criteria  after  the  T-tube  trial  of  30  minutes  were  extubated.  The  patients  were  kept  on
VM for  1  hour  to  observe  the  hemodynamic  and  respiratory  stability.  The  group  of  50  patients
who were  successful  to  wean  randomly  allocated  to  have  either  VM  (n  =  25),  or  NIV  (n  =  25).
Systolic arterial  pressure  (SAP),  heart  rate  (HR),  respiratory  rate  (RR),  PaO2,  PCO2,  and  pH
values were  recorded.
Results:  The  number  of  patients  who  developed  respiratory  failure  in  the  NIV  group  was  sig-
niﬁcantly  less  than  VM  group  of  patients  (3  reintubation  vs.  14  NIV  +  5  reintubation  in  the  VM
group). The  length  of  stay  in  the  ICU  was  also  signiﬁcantly  shorter  in  NIV  group  (5.2  ±  4.9  vs.
16.7 ±  7.7  days).
Conclusions:  The  ratio  of  the  respiratory  failure  and  the  length  of  stay  in  the  ICU  were  lower
when non-invasive  mechanical  ventilation  was  used  after  extubation  even  if  the  patient  is
regarded as  ‘successfully  weaned’.  We  recommend  the  use  of  NIMV  in  such  patients  to  avoid
unexpected  ventilator  failure.a  de  Anestesiologia.  Published  by  Elsevier  Editora  Ltda.  This  is  an
he  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-© 2015  Sociedade  Brasileir
open access  article  under  t
nc-nd/4.0/).∗ Corresponding author.
E-mail: gturanmd@yahoo.com (G. Turan).
ttp://dx.doi.org/10.1016/j.bjane.2014.11.008
104-0014/© 2015 Sociedade Brasileira de Anestesiologia. Published by Elsevier Editora Ltda. This is an open access article under the CC
Y-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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PALAVRAS-CHAVE
Respirac¸ão  artiﬁcial;
Desmame;
Cuidados  intensivos
Ventilac¸ão  mecânica  não  invasiva  após  desmame  bem-sucedido:  uma  comparac¸ão
com  a  máscara  de  Venturi
Resumo
Justiﬁcativa  e  objetivos:  Este  estudo  comparou  as  taxas  de  insuﬁciência  respiratória  aguda,
reintubac¸ão, tempo  de  internac¸ão  em  UTI  e  mortalidade  em  pacientes  sob  ventilac¸ão  mecânica
não invasiva  (VMNI)  em  vez  da  habitual  máscara  facial  de  Venturi  (MV)  após  desmame  bem-
sucedido.
Métodos:  Após  a  aprovac¸ão  do  Comitê  de  Ética  do  hospital,  62  pacientes  que  estavam  sob
ventilac¸ão mecânica  por  no  mínimo  48  horas  foram  inscritos  neste  estudo.  Doze  pacientes
foram excluídos  devido  à  falha  de  desmame  durante  o  teste  de  tubo-T.  Os  pacientes  que  apre-
sentaram critérios  de  desmame  ótimos  após  o  teste  de  tubo-T  de  30  minutos  foram  extubados.
Os pacientes  foram  mantidos  em  MV  por  1  hora  para  observac¸ão  da  estabilidade  hemodinâmica
e respiratória.  O  grupo  de  50  pacientes  que  obtiveram  sucesso  no  desmame  ventilatório  foram
alocados aleatoriamente  para  MV  (n  =  25)  ou  VNI  (n  =  25).  Os  valores  de  pressão  arterial  sistólica
(PAS), frequência  cardíaca  (FC),  frequência  respiratória  (FR),  PaO2,  PCO2 e  pH  foram  registra-
dos.
Resultados:  O  número  de  pacientes  que  desenvolveu  insuﬁciência  respiratória  no  grupo  VNI  foi
signiﬁcativamente  menor  que  o  do  grupo  MV  (3reintubac¸ões  vs.  14  VNI  +  5  reintubac¸ões  no
grupo MV).  O  tempo  de  permanência  em  UTI  também  foi  signiﬁcativamente  menor  no  grupo  NIV
(5,2 ±  4,9  vs.  16,7  ±  7,7  dias).
Conclusões:  As  taxas  de  insuﬁciência  respiratória  e  do  tempo  de  permanência  em  UTI  foram
menores quando  a  ventilac¸ão  mecânica  não  invasiva  foi  usada  após  a  extubac¸ão,  mesmo  se  o
paciente for  considerado  como  ‘‘desmame  bem-sucedido’’.  Recomendamos  o  uso  de  VMNI  em
tais pacientes  para  evitar  a  falha  inesperada  do  ventilador.
© 2015  Sociedade  Brasileira  de  Anestesiologia.  Publicado  por  Elsevier  Editora  Ltda.  Este e´  um
artigo Open  Access  sob  uma  licenc¸a  CC  BY-NC-ND  (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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(Introduction
Non-invasive  ventilation  takes  a  role  in  different  stages  of
treatment  in  intensive  care  units.  This  method  is  commonly
used  as  an  alternative  to  invasive  ventilation  in  patients  who
are  clinically  stable  but  suffer  from  acute  hypercapnic  respi-
ratory  failure.1--3 NIV  is  also  used  for  premature  weaning
and  post  extubation  respiratory  failure  and  positive  results
on  reintubation  and  duration  of  intensive  care  unit  stay  is
reported.4
In  this  study,  we  aimed  to  determine  if  prophylactic  NIV
applied  to  the  patients  who  were  extubated  according  to
the  standardized  weaning  criteria  and  who  were  appropri-
ate  for  following  with  venture  face  mask  (VM)  would  make
any  difference  in  terms  of  respiratory  failure  after  extuba-
tion,  reintubation,  duration  of  intensive  care  unit  stay  and
mortality.
Materials and methods
Sixty-two  patients  above  18-years  old  who  were  admitted
to  intensive  care  unit  with  acute  respiratory  failure  and
treated  with  invasive  mechanical  ventilatory  support  for
more  than  48  h  were  included  in  the  study.  Patients  whose
APACHE  II  (Acute  Physiology  and  Chronic  Health  Evaluation
II)  score  above  25,  GCS  (Glasgow  Coma  Scale)  below  13
and  who  have  contraindications  for  NIV  (patients  with  max-
illofacial  trauma,  gastrointestinal  obstruction  and  severe
g
f
N
fecretion),  severe  irreversible  organ  failure  and  pregnancy
ere  excluded  from  the  study.  Demographic  data,  diag-
osis,  comorbidities,  and  APACHE  II  scores  of  the  patients
ere  recorded.  Weaning  was  planned  for  the  patients  who
ave  optimal  conditions:  CPAP  mode  with  invasive  mechanic
entilation  support  who  have  FiO  ≤  40,  PaO2 ≥  60,  PEEP  ≤  5,
O2 ≥  90  and  not  having  inotrope  support;  systolic  arte-
ial  pressure  between  70  and  180  mmHg,  peak  heart  rate
etween  50  and  140  min,  respiratory  rate  <  25  min,  GCS  ≥  13.
atients  who  fulﬁlled  these  criteria  were  taken  under  spon-
aneous  respiratory  trial  with  T-part  for  30  min.  Arterial
lood  gas  was  evaluated  after  30  min  spontaneous  respira-
ory  trial.  If  hemodynamic  and  respiratory  parameters  were
table,  patients  were  extubated  and  supported  with  O2 by
M.  Patients  were  followed  up  for  an  hour  to  observe  sufﬁ-
iency  in  terms  of  weaning  and  the  ones  who  had  SO2 ≥  90,
ystolic  arterial  pressure  between  70  and  180  mmHg,  peak
eart  rate  between  50  and  140  min,  respiratory  rate  <  25  min
ere  included  in  the  study.  The  patients  were  chosen  into
he  groups  according  to  the  admission  number  as  having  odd
r  even  number.
At  the  end  of  the  ﬁrst  hour,  the  patients  who  could  not
rovide  these  parameters  and  impaired  hemodynamics  or
espiratory  pattern,  were  return  to  mechanical  ventilation
IMV  or  NIV)  and  excluded  from  the  study.  While  one  of  the
roups  (Group  VM)  were  continued  to  have  O2 support  by  VM
rom  the  ﬁrst  hour  of  extubation,  the  other  group  (Group
IV)  were  put  on  NIV  from  the  ﬁrst  hour  of  extubation.  The
unction  of  the  NIV  was  explained  to  the  patients  in  NIV
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Table  1  Baseline  characteristics  of  the  patients.
Group  VM  Group  NIV  p-value
Age  67.84  ±  17.31  71.88  ±  11.00  0.330
Sex
F 15  (60%) 12  (48%) 0.395
M 10  (40%)  13  (52%)
APACHE  II  20.76  ±  7.03  19.54  ±  4.46  0.474
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roup.  Mechanical  ventilation  parameters  of  the  patients
upported  by  NIV  were  set  as  IPAP:  13--15  cm  H2O  vs.  EPAP:
--5  cm  H2O  according  to  patient  compliance.  Different  types
f  NIV  masks  (full-face  and  oronasal-forehead  or  chin  sup-
orted)  were  chosen  for  application  in  order  to  provide
atient  comfort  and  compliance.  During  the  follow-up,  low
ose  dexmedetomidine  sedation  (0.2--0.5  mg/kg/h  infusion)
as  planned  to  be  initiated  if  the  patient’s  incompliance  was
reventing  NIV  to  be  effective.
Arterial  pressure,  pulse,  respiratory  rate  and  arterial
lood  gas  parameters  were  recorded  before  extubation,
nder  IMV  in  CPAP  mode;  in  the  30th  minute  of  T-piece  trial;
nd  after  extubation  in  1st,  2nd,  3rd,  4th,  5th,  6th,  12th,
4th,  48th  hours  in  all  patients.  Complications  (vomiting,
irway  obstruction,  regurgitation,  etc.)  were  recorded.
In  Group  VM,  patients  who  did  not  have  respiratory  failure
nd  intubation  indication  but  developed  respiratory  deterio-
ation  and  slight  hypoxia  (respiratory  rate  >  25  min,  SO2 ≤  95,
aO2 ≤  70  mmHg)  were  supported  with  NIV;  while  patients  in
oth  groups  who  had  respiratory  failure  and  intubation  indi-
ation  (respiratory  rate  >  35  min,  SO2 <  90,  PaO2 <  60  mmHg
nd  hemodynamic  failure)  were  reintubated.
Continuity  of  weaning  success,  respiratory  failure  after
xtubation,  reintubation,  duration  of  intensive  care  unit
tay  and  mortality  rates  are  compared  between  two
roups.
During  the  evaluation  of  the  data  obtained  from  the
tudy,  SPSS  (Statistical  Package  for  Social  Sciences)  for  Win-
ows  20.0  program  was  used  for  the  statistical  analysis.
istribution  of  variables  was  controlled  by  using  Kolmogorov
mirnov  Test.  During  the  evaluation  of  the  study  data,
egarding  the  comparisons  of  descriptive  statistical  meth-
ds  (frequency,  rate,  mean,  and  standard  deviation)  as  well
s  quantitative  data,  Student  t test  and  Mann  Whitney  U
ests  were  used.  Chi-square  test  was  used  regarding  the
omparison  of  the  qualitative  data.  Paired  sample  t  test  and
ilcoxon  tests  were  used  for  repetitive  measurements.  The
esults  obtained  from  the  study  were  evaluated  within  95%
onﬁdence  intervals  and  at  a  signiﬁcance  level  of  p  <  0.05
evel.
esults
he  study  was  conducted  on  62  patients  with  acute  respira-
ory  failure  who  were  hospitalized  in  the  intensive  care  unit
f  our  clinic  and  had  invasive  mechanical  ventilatory  sup-
ort  for  more  than  48  h.  Eleven  of  these  cases  developing
espiratory  failure  in  the  1st  hour  of  extubation  and  1  case
perated  for  acute  abdomen  on  the  12th  hour  of  the  study
ere  excluded  from  the  study.  The  remaining  50  patients
n  both  groups  who  were  followed-up  with  VM  after  a  suc-
essful  weaning  for  1  h  were  included  in  the  study.  There
as  no  signiﬁcant  difference  between  two  groups  regarding
ge,  gender  distribution  and  APACHE  II  scores  (p  >  0.05)
Table  1).
The  study  period  was  48  h  after  extubation.  Systolic  blood
ressure,  peak  heart  rate,  respiratory  rate,  PaO2 and  PaCO2
nd  pH  values  were  recorded  and  compared  at  certain  time
ntervals.
When  T-circuit  was  at  the  30th  minute  in  Group  VM  and
roup  NIV,  there  was  no  signiﬁcant  difference  (p  >  0.05)
b
f
(
retween  systolic  blood  pressure  values  in  the  1st,  2nd,  3rd,
th,  5th,  6th,  12th,  24th,  48th  hours.
When  T-circuit  was  at  the  30th  minute  in  Group  VM  and
roup  NIV,  there  was  no  signiﬁcant  difference  (p  >  0.05)
etween  peak  heart  rate  values  in  the  1st,  2nd,  3rd,  4th,
th,  6th,  12th,  24th,  48th  hours.  Group  VM  had  signiﬁcantly
igher  pulse  rates  (p  <  0.05)  than  Group  NIV  in  the  2nd  hour
98.7  ±  15.1;  90.3  ±  13.6;  p =  0.045).
When  T-circuit  was  at  the  30th  minute  in  Group  VM  and
roup  NIV,  there  was  no  signiﬁcant  difference  (p  >  0.05)
etween  respiratory  rate  (RR)  values  in  the  1st,  2nd,  3rd,
th,  5th,  6th,  12th,  24th,  48th  hours.
When  T-circuit  was  at  the  30th  minute  in  Group  VM  and
roup  NIV,  there  was  no  signiﬁcant  difference  (p  >  0.05)
etween  PCO2 values  in  the  1st,  6th,  12th,  24th,  48th  hours.
When  T-circuit  was  at  the  30th  minute  in  Group  VM  and
roup  NIV,  there  was  no  signiﬁcant  difference  (p  >  0.05)
etween  PO2 values  in  the  1st,  12th,  24th,  48th  hours.  Group
M  had  signiﬁcantly  lower  PO2 values  (p  <  0.05)  than  Group
IV  in  the  6th  hour  (90.2  ±  25.6;  112  ±  29.2;  p  =  0.015).
Respiratory  failure  developed  in  19  of  the  25  patients
76%)  in  Group  VM,  whereas  it  developed  only  in  3  (12%)
f  the  25  patients  in  Group  NIV  after  extubation.  In  group
M,  14  of  the  19  patients  (73%)  NIV  support  was  initiated,  5
atients  (26%)  were  directly  reintubated.  Four  (80%)  of  the
 patients  who  were  directly  reintubated  were  died  after
he  48  h  study  period,  during  their  stay  in  ICU  with  pro-
ressive  respiratory  failure  due  to  COPD  +  Pnemonia  in  one
nd  with  acute  cerebral  bleeding,  malignancy,  abdominal
epsis  developed  after  colon  perforation  in  the  other  three
atients.
Respiratory  failure  developed  after  extubation  in  only  3
12%)  of  25  patients  of  group  followed  with  NIV  and  they
ere  reintubated.  Two  (66%)  of  these  were  died  after  the
tudy  period  before  weaning.  The  causes  of  deaths  were
gain  related  to  the  extrapulmonary  reasons  (acute  cere-
rovascular  occlusion  and  acute  coronary  syndrome).
NIV  was  provided  in  14  patients  (56%)  in  Group  VM  devel-
ping  respiratory  failure  during  follow-up  with  venturi  mask
nd  they  could  be  discharged  from  the  hospital  without  any
eed  of  reintubation.  In  group  VM  patients  who  needed  NIV
upport,  a  signiﬁcant  decrease  was  observed  in  PO2 value  at
he  6th--12th  hours  and  a  signiﬁcant  increase  VM.
The  use  of  NIV  support  decreased  respiratory  failure  ratio
fter  extubation  by  64%,  and  reintubation  and  mortality  rate
y  8%.  Comparing  the  two  groups  in  terms  of  respiratory
ailure  after  extubation  a  signiﬁcant  difference  was  seen
p  <  0.05).  No  signiﬁcant  difference  was  detected  regarding
eintubation  and  mortality  ratios  (p  >  0.05)  (Table  2).
Non-invasive  mechanical  ventilation  
Table  2  No  signiﬁcant  difference  was  detected  regarding
reintubation  and  mortality  ratios.
Group  VM  Group  NIV  p-value
Respiratory  failure
after  extubation
19  (76%)  3  (12%)  0.000
Reintubation  5  (20%)  3  (12%)  0.702
Duration  of  intensive
care  unit  stay
16.7  ±  7.7  5.2  ±  4.9  0.000
Outcome
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mExit 4  (16%)  2  (8%)  0.304
Alive 21  (84%) 23  (92%)
Discussion
Current  routine  clinical  practice  of  the  weaning  process  is
to  extubate  the  patients  eligible  for  weaning  criteria  and
follow-up  the  group  who  seem  to  be  stabilized  in  terms  of
respiration  with  VM.
While  this  process  is  well  tolerated  by  some  patients
and  weaning  process  can  easily  be  completed,  during  pro-
longed  VM  period,  some  patients  may  need  respiratory
support  due  to  insufﬁciency  of  ventilation  capacity,  rapid
superﬁcial  breathing,  inability  to  protect  airway,  secretion
collection  and  atelectasis  formation  in  the  advancing  hours
even  though  they  seem  to  be  stabile  in  the  ﬁrst  hours  of  the
process.4--7 To  be  insistent  on  VM  follow-up  for  these  groups
of  patients  may  cause  the  patient  to  lose  the  opportunity  for
NIV  leading  to  the  reintubation  process  with  accompanying
risks.
We  performed  our  study  on  the  patients  who  fulﬁlled  the
weaning  criteria,  kept  respiratory  and  hemodynamic  sta-
bility  after  30  min  T-piece  trial  and  then  extubated.  We
aimed  to  observe  the  effects  of  NIV  support  on  respira-
tory  failure  development,  duration  of  stay  in  the  intensive
care  unit  and  mortality  rates  in  this  patient  group  who
were  allowable  for  follow-up  with  venturi  mask,  namely
the  patients  for  whom  respiratory  failure  were  not  foreseen
under  normal  conditions.  We  preferred  to  use  NIV  support
continuously  for  48  h  in  our  patients.  However,  we  also  car-
ried  out  a  protocol  based  on  care,  feeding  and  short  rest
intervals  considering  patient  comfort.  When  the  patients
with  oronasal  mask  were  observed  to  have  nasal  pressure,
full-face  mask  alternative  was  used  to  prevent  nasal  injury.
None  of  the  patients  suffered  from  complications  such  as
gastric  distension,  regurgitation  and  vomiting  and  there  was
no  need  for  sedation  in  any  group.
Nava  et  al.  investigated  NIV  use  in  patients  fulﬁlling
weaning  criteria  but  at  risk  for  respiratory  failure  after
extubation  also  used  a  similar  method  (successive  NIV  appli-
cations  in  the  ﬁrst  48  h).  In  this  study,  97  patients  were
divided  into  two  groups  as  standard  medical  treatment  (VM)
or  NIV  use.  While  12  of  49  patients  in  control  group  were
reintubated,  4  of  48  patients  in  NIV  group  were  reintubated
(p  =  0.027).  Hence,  the  use  of  NIV  decreased  reintubation
by  16%  and  the  risk  of  intensive  care  unit  mortality  by  10%
(p  <  0.01).  Besides  these,  need  for  reintubation  was  found
to  be  associated  with  a  60%  increase  in  the  risk  of  inten-
sive  care  unit  mortality  (p  <  0.01).  When  durations  of  stay
in  the  intensive  care  unit  of  the  patients  with  reintubation
t
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eed  were  compared  with  the  other  patients,  it  was  seen
hat  it  was  statistically  signiﬁcantly  longer  (28.3  ±  29.5  vs.
.6  ±  5.1).  These  researchers  concluded  that  the  inhibitory
se  of  NIV  decreased  the  requirement  of  reintubation  in
atient  subgroups  passing  spontaneous  breathing  trials  but
aving  respiratory  failure  risk  after  extubation.5
Similar  results  were  found  in  another  study  performed
y  Ferrer  et  al.6 In  this  study,  like  ours,  NIV  was  used  as
n  preventive  treatment  method  for  the  patients  who  were
uccessfully  weaned  after  the  T-piece  trial,  and  compared  to
he  control  group  who  had  venturi  mask  instead.  As  a  result
f  the  study  performed  on  162  patients,  researchers  found
hat  the  use  of  NIV  decreased  the  incidence  of  respiratory
ailure  after  extubation  considerably  and  intensive  care  unit
ortality  rate  also  decreased.  However,  they  could  not  ﬁnd
 signiﬁcant  difference  between  90-day  survival  rates  of  the
wo  groups.
We  chose  our  study  group  from  the  patients  in  whom
espiratory  failure  was  not  foreseen  after  extubation.  If  any
eterioration  during  the  follow-up  period  occurs;  that  is:
espiratory  rate  above  25  breaths/min,  SO2: 90%  and  below;
O2:  70  mmHg  and  below;  NIV  applied  to  the  patient  under
M.  If  the  respiratory  rate  above  35  breaths/min,  SO2:  90%
nd  below;  PO2:  60  mmHg  and  below  or  the  hemodynamic
arameters  were  impaired,  the  patients  in  both  groups  were
irectly  intubated  to  have  invasive  mechanical  ventilator
upport.  NIV  was  provided  in  14  patients  (56%)  in  Group  VM
eveloping  respiratory  failure  during  follow-up  with  venturi
ask  and  these  patients  could  be  discharged  from  hospital
ithout  any  need  of  reintubation.
In  their  study  performed  on  158  patients,  Meduri  et  al.7
howed  that  NIV  could  be  an  effective  method  to  treat  respi-
atory  failure  after  extubation  and  65--70%  of  the  patients
hose  reintubation  was  unavoidable  could  beneﬁt  from  NIV.
hirty-nine  of  these  patients  were  supported  with  NIV  due  to
espiratory  failure  after  extubation  and  an  improvement  was
bserved  in  arterial  blood  gas  values  of  88%  of  them.  There-
ore,  the  need  for  reintubation  removed  in  65%  of  these
atients.
Problems  originating  from  the  cardiovascular  system  can
e  a  hidden  cause  of  weaning  failure.  Respiratory  muscle
athology  can  be  found  in  the  patients  with  heart  failure
ue  to  inspiratory  muscles  overload  or  generalized  muscular
trophy  and  muscle  weakness  related  to  cardiac,  cachexia
r  decrease  in  respiratory  muscle  blood  ﬂow.  Respiratory
uscle  abnormality  is  an  important  pathology  contributing
o  the  development  of  respiratory  failure  in  these  patients.
n  the  studies  performed,  it  was  shown  that  NIV  support
ad  beneﬁcial  effects  on  respiratory  muscles  in  acute  and
hronic  heart  failure.  In  their  studies,  Lemaire  et  al.  showed
hat  there  were  direct  increases  in  transmural  pulmonary
rterial  occlusion  pressure  during  T-piece  application  and
his  increase  could  be  avoided  with  application  of  intratho-
acic  pressure  with  NIV  support  by  decreasing  preload  and
fter  load  of  the  heart.  Although  none  of  our  patients  had
cute  heart  failure,  mean  age  of  the  groups  were  67  ±  17
ears  in  Group  VM  and  71  ±  11  years  in  Group  NIV,  that  may
ean  some  degree  of  cardiac  dysfunction  might  be  a  con-ributing  factor  for  their  respiratory  distress.  So,  we  can  say
hat  favorable  effects  on  cardiac  functions  might  have  also
een  a  beneﬁcial  factor  for  pulmonary  recovery  in  patients
dministered  with  NIV  support.
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NIV  support  could  be  used  carefully  in  patients  devel-
ping  respiratory  failure  after  extubation  but  it  should  be
aken  into  consideration  that  dangerous  delays  in  reintuba-
ion  during  treatment  of  respiratory  failure  after  extubation
ith  NIV  support  could  result  in  adverse  outcomes  for  the
atients.  In  their  meta-analysis  performed  by  reviewing  the
tudies  on  this  subject,  Agarwal  et  al.  concluded  that  it  is
uggested  that  protocols  should  be  developed  for  NIV  use  in
he  patients  at  risk  for  developing  respiratory  failure  after
xtubation.8
In  our  study,  we  observed  that  provision  of  prophylactic
IV  support  for  at  least  48  h  after  weaning  under  opti-
al  conditions  in  the  patients  who  had  invasive  mechanical
entilatory  support  for  more  than  48  h  due  to  acute  respi-
atory  failure  and  for  whom  respiratory  failure  were  not
oreseen  after  extubation  decreased  the  duration  of  stay
n  the  intensive  care  unit  and  risk  for  respiratory  fail-
re  that  could  develop.  Although  the  use  of  NIV  is  not
uggested  except  the  patients  at  high  risk  for  extuba-
ion  success;  based  on  the  results  we  obtained  from  our
tudy,  we  consider  that  the  prophylactic  use  of  NIV  can  be
eneﬁcial.onﬂicts of interest
he  authors  declare  no  conﬂicts  of  interest.
8E.  Adıyeke  et  al.
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